These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22272901)

  • 41. Statins in community acquired pneumonia: Evidence from experimental and clinical studies.
    Chalmers JD; Short PM; Mandal P; Akram AR; Hill AT
    Respir Med; 2010 Aug; 104(8):1081-91. PubMed ID: 20447815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin therapy prior to hospitalization does not significantly influence sepsis presentation or sepsis outcomes. A prospective, observational study.
    Azkarate I; Díez M; Ganzarain M; Salas E; Choperena G; Eguibar I
    Med Clin (Barc); 2021 Jan; 156(1):13-16. PubMed ID: 32402386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrating outcome benefit into anesthetic design: the promise of steroids and statins.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):880-4. PubMed ID: 21962304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
    Krysiak R; Okopień B; Herman Z
    Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Statin therapy-evidence beyond lipid lowering contributing to plaque stability.
    de Lorenzo F; Feher M; Martin J; Collot-Teixeira S; Dotsenko O; McGregor JL
    Curr Med Chem; 2006; 13(28):3385-93. PubMed ID: 17168712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of statins on liver cell function and inflammation in septic rats.
    Stolf AM; Lívero Fdos R; Dreifuss AA; Bastos-Pereira AL; Fabosi IA; Alves de Souza CE; Gomes Lde O; Chicorski R; Brandt AP; Cadena SM; Telles JE; Hauser AB; Elferink RO; Zampronio AR; Acco A
    J Surg Res; 2012 Dec; 178(2):888-97. PubMed ID: 22954522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuation of statin therapy in patients with presumed infection: a randomized controlled trial.
    Kruger PS; Harward ML; Jones MA; Joyce CJ; Kostner KM; Roberts MS; Venkatesh B
    Am J Respir Crit Care Med; 2011 Mar; 183(6):774-81. PubMed ID: 20959555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases.
    Almog Y; Novack V; Eisinger M; Porath A; Novack L; Gilutz H
    Crit Care Med; 2007 Feb; 35(2):372-8. PubMed ID: 17205009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statins: the next step in adjuvant therapy for sepsis?
    Mekontso-Dessap A; Brun-Buisson C
    Intensive Care Med; 2006 Jan; 32(1):11-4. PubMed ID: 16283158
    [No Abstract]   [Full Text] [Related]  

  • 51. Statins in heart failure. Beyond the lipid lowering effect.
    Tousoulis D; Charakida M; Stefanadi E; Siasos G; Latsios G; Stefanadis C
    Int J Cardiol; 2007 Feb; 115(2):144-50. PubMed ID: 17175040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pleiotropic effects of statins.
    Farmer JA
    Curr Atheroscler Rep; 2000 May; 2(3):208-17. PubMed ID: 11122746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. View of statins as antimicrobials in cardiovascular risk modification.
    Kozarov E; Padro T; Badimon L
    Cardiovasc Res; 2014 Jun; 102(3):362-74. PubMed ID: 24623278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.
    Egom EE; Rose RA; Neyses L; Soran H; Cleland JG; Mamas MA
    Crit Rev Clin Lab Sci; 2013; 50(3):79-89. PubMed ID: 23885725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis.
    Hackam DG; Mamdani M; Li P; Redelmeier DA
    Lancet; 2006 Feb; 367(9508):413-8. PubMed ID: 16458766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Statins prevent cognitive impairment after sepsis by reverting neuroinflammation, and microcirculatory/endothelial dysfunction.
    Reis PA; Alexandre PCB; D'Avila JC; Siqueira LD; Antunes B; Estato V; Tibiriça EV; Verdonk F; Sharshar T; Chrétien F; Castro-Faria-Neto HC; Bozza FA
    Brain Behav Immun; 2017 Feb; 60():293-303. PubMed ID: 27833044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statin pleiotropy: fact or fiction?
    Futterman LG; Lemberg L
    Am J Crit Care; 2004 May; 13(3):244-9. PubMed ID: 15149060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statins for the prevention and treatment of infections: a systematic review and meta-analysis.
    Tleyjeh IM; Kashour T; Hakim FA; Zimmerman VA; Erwin PJ; Sutton AJ; Ibrahim T
    Arch Intern Med; 2009 Oct; 169(18):1658-67. PubMed ID: 19822822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statin use in heart failure: a cause for concern?
    Raina A; Pickering T; Shimbo D
    Am Heart J; 2006 Jul; 152(1):39-49. PubMed ID: 16824830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.